APO RESEARCH · REPORT
Vitamin B12 (Cobalamin, Cyanocobalamin)
Vitamin B12 is a nutrient that helps keep the body's nerve and blood cells healthy and helps make DNA, the genetic material in all cells. Vitamin B12 also helps prevent a type of anemia called megaloblastic anemia that makes people tired and weak.
Product & engineering
Understand the product.
Vitamin B12 is a nutrient that helps keep the body's nerve and blood cells healthy and helps make DNA, the genetic material in all cells. Vitamin B12 also helps prevent a type of anemia called megaloblastic anemia that makes people tired and weak.
Selected research
Industry Research
Vitamin B12 (Cobalamin, Cyanocobalamin) Industry Research Report 2026
Market perspective
Vitamin B12 is a nutrient that helps keep the body's nerve and blood cells healthy and helps make DNA, the genetic material in all cells. Vitamin B12 also helps prevent a type of anemia called megaloblastic anemia that makes people tired and weak.
The industry's leading manufacturers are Sanofi-Aventis, Merck and Pfizer, with a combined revenue share of 26.08% in 2019.
Report Scope
Read the full market overview
This report quantifies the global Vitamin B12 (Cobalamin, Cyanocobalamin) market in terms of revenue (US$ million) and, where applicable, sales volume (K Units), using 2025 as the base year and providing annual historical and forecast data for 2021–2032.
It standardizes definitions of Types and Applications, harmonizes vendor attribution, and presents comparable time series by company, Type, Application, and region/country, including indicative price bands (US$/K Units) and concentration ratios (CR5/CR10).
The outputs are intended to support strategy development, budgeting, and performance benchmarking for brand owners, manufacturers, retailers, channel partners, and investors; data are structured with consistent units and fields to facilitate integration into internal FP&A and BI systems.
Key Companies & Market Share Insights
This section profiles leading manufacturers, combining 2021–2025 results with a 2026–2032 outlook. It reports revenue, market share, price bands, product and application mix, regional and channel mix, and key developments (M&A, capacity additions, certifications). It also provides global revenue, average price, and—where applicable—sales volume by manufacturer, and calculates CR5/CR10 and rank changes to support comparative benchmarking.
Vitamin B12 (Cobalamin, Cyanocobalamin) Market by Company
Luitpold Pharmaceuticals (Daiichi Sankyo)
Endo International
Sanofi-Aventis
Jamieson
Novartis
Teva (Actavis)
Merck
Mylan
Bayer HealthCare
Pfizer
ANGELINI
Biological E
CCEPCD
Huaxin Pharmaceutical
RLG Group
Vitamin B12 (Cobalamin, Cyanocobalamin) Segment by Type
Cyanocobalamin Injection
Cyanocobalamin Oral
Cyanocobalamin Spray
Vitamin B12 (Cobalamin, Cyanocobalamin) Segment by Application
Hospitals
Clinics
Drugstore
Others
Vitamin B12 (Cobalamin, Cyanocobalamin) Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Vitamin B12 (Cobalamin, Cyanocobalamin) market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Vitamin B12 (Cobalamin, Cyanocobalamin) and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Vitamin B12 (Cobalamin, Cyanocobalamin).
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Research objectives, research methods, data sources, data cross-validation;
Chapter 2: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc.), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 3: Detailed analysis of Vitamin B12 (Cobalamin, Cyanocobalamin) manufacturers competitive landscape, price, production and value market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product production/output, value, price, gross margin, product introduction, recent development, etc.
Chapter 5: Production/output, value of Vitamin B12 (Cobalamin, Cyanocobalamin) by region/country. It provides a quantitative analysis of the market size and development potential of each region in the next six years.
Chapter 6: Consumption of Vitamin B12 (Cobalamin, Cyanocobalamin) in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and production of each country in the world.
Chapter 7: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 8: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 11: The main points and conclusions of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- Cyanocobalamin Injection
- Cyanocobalamin Oral
- Cyanocobalamin Spray
Applications
- Hospitals
- Clinics
- Drugstore
- Others
Companies covered
- Luitpold Pharmaceuticals (Daiichi Sankyo)
- Endo International
- Sanofi-Aventis
- Jamieson
- Novartis
- Teva (Actavis)
- Merck
- Mylan
- Bayer HealthCare
- Pfizer
- ANGELINI
- Biological E
- CCEPCD
- Huaxin Pharmaceutical
- RLG Group
Inside the report.
1 Preface
- 1.1 Scope of Report
- 1.2 Reasons for Doing This Study
- 1.3 Research Methodology
- 1.4 Research Process
- 1.5 Data Source
- 1.5.1 Secondary Sources
- 1.5.2 Primary Sources
2 Market Overview
- 2.1 Product Definition
- 2.2 Global Market Growth Prospects
- 2.2.1 Global Vitamin B12 (Cobalamin, Cyanocobalamin) Market Size (2021-2032)
- 2.2.2 Global Vitamin B12 (Cobalamin, Cyanocobalamin) Sales (2021-2032)
- 2.2.3 Global Vitamin B12 (Cobalamin, Cyanocobalamin) Market Average Price (2021-2032)
- 2.3 Vitamin B12 (Cobalamin, Cyanocobalamin) by Type
- 2.3.1 Market Value Comparison by Type (2021 VS 2025 VS 2032) & (US$ Million)
- 2.3.2 Cyanocobalamin Injection
- 2.3.3 Cyanocobalamin Oral
- 2.3.4 Cyanocobalamin Spray
- 2.4 Vitamin B12 (Cobalamin, Cyanocobalamin) by Application
- 2.4.1 Market Value Comparison by Application (2021 VS 2025 VS 2032)
- 2.4.2 Hospitals
- 2.4.3 Clinics
- 2.4.4 Drugstore
- 2.4.5 Others
3 Market Competitive Landscape by Manufacturers
- 3.1 Global Vitamin B12 (Cobalamin, Cyanocobalamin) Market Competitive Situation by Manufacturers (2021 Versus 2025)
- 3.2 Global Vitamin B12 (Cobalamin, Cyanocobalamin) Sales (K Units) of Manufacturers (2021-2026)
- 3.3 Global Vitamin B12 (Cobalamin, Cyanocobalamin) Revenue of Manufacturers (2021-2026)
- 3.4 Global Vitamin B12 (Cobalamin, Cyanocobalamin) Average Price by Manufacturers (2021-2026)
- 3.5 Global Vitamin B12 (Cobalamin, Cyanocobalamin) Industry Ranking, 2024 VS 2025 VS 2026
- 3.6 Global Manufacturers of Vitamin B12 (Cobalamin, Cyanocobalamin), Manufacturing Sites & Headquarters
- 3.7 Global Manufacturers of Vitamin B12 (Cobalamin, Cyanocobalamin), Product Type & Application
- 3.8 Global Manufacturers of Vitamin B12 (Cobalamin, Cyanocobalamin), Established Date
- 3.9 Global Vitamin B12 (Cobalamin, Cyanocobalamin) Market CR5 and HHI
- 3.10 Global Manufacturers Mergers & Acquisition
4 Manufacturers Profiled
- 4.1 Luitpold Pharmaceuticals (Daiichi Sankyo)
- 4.1.1 Luitpold Pharmaceuticals (Daiichi Sankyo) Company Information
- 4.1.2 Luitpold Pharmaceuticals (Daiichi Sankyo) Business Overview
- 4.1.3 Luitpold Pharmaceuticals (Daiichi Sankyo) Vitamin B12 (Cobalamin, Cyanocobalamin) Sales, Revenue and Gross Margin (2021-2026)
- 4.1.4 Luitpold Pharmaceuticals (Daiichi Sankyo) Vitamin B12 (Cobalamin, Cyanocobalamin) Product Portfolio
- 4.1.5 Luitpold Pharmaceuticals (Daiichi Sankyo) Recent Developments
- 4.2 Endo International
- 4.2.1 Endo International Company Information
- 4.2.2 Endo International Business Overview
- 4.2.3 Endo International Vitamin B12 (Cobalamin, Cyanocobalamin) Sales, Revenue and Gross Margin (2021-2026)
- 4.2.4 Endo International Vitamin B12 (Cobalamin, Cyanocobalamin) Product Portfolio
- 4.2.5 Endo International Recent Developments
- 4.3 Sanofi-Aventis
- 4.3.1 Sanofi-Aventis Company Information
- 4.3.2 Sanofi-Aventis Business Overview
- 4.3.3 Sanofi-Aventis Vitamin B12 (Cobalamin, Cyanocobalamin) Sales, Revenue and Gross Margin (2021-2026)
- 4.3.4 Sanofi-Aventis Vitamin B12 (Cobalamin, Cyanocobalamin) Product Portfolio
- 4.3.5 Sanofi-Aventis Recent Developments
- 4.4 Jamieson
- 4.4.1 Jamieson Company Information
- 4.4.2 Jamieson Business Overview
- 4.4.3 Jamieson Vitamin B12 (Cobalamin, Cyanocobalamin) Sales, Revenue and Gross Margin (2021-2026)
- 4.4.4 Jamieson Vitamin B12 (Cobalamin, Cyanocobalamin) Product Portfolio
- 4.4.5 Jamieson Recent Developments
- 4.5 Novartis
- 4.5.1 Novartis Company Information
- 4.5.2 Novartis Business Overview
- 4.5.3 Novartis Vitamin B12 (Cobalamin, Cyanocobalamin) Sales, Revenue and Gross Margin (2021-2026)
- 4.5.4 Novartis Vitamin B12 (Cobalamin, Cyanocobalamin) Product Portfolio
- 4.5.5 Novartis Recent Developments
- 4.6 Teva (Actavis)
- 4.6.1 Teva (Actavis) Company Information
- 4.6.2 Teva (Actavis) Business Overview
- 4.6.3 Teva (Actavis) Vitamin B12 (Cobalamin, Cyanocobalamin) Sales, Revenue and Gross Margin (2021-2026)
- 4.6.4 Teva (Actavis) Vitamin B12 (Cobalamin, Cyanocobalamin) Product Portfolio
- 4.6.5 Teva (Actavis) Recent Developments
- 4.7 Merck
- 4.7.1 Merck Company Information
- 4.7.2 Merck Business Overview
- 4.7.3 Merck Vitamin B12 (Cobalamin, Cyanocobalamin) Sales, Revenue and Gross Margin (2021-2026)
- 4.7.4 Merck Vitamin B12 (Cobalamin, Cyanocobalamin) Product Portfolio
- 4.7.5 Merck Recent Developments
- 4.8 Mylan
- 4.8.1 Mylan Company Information
- 4.8.2 Mylan Business Overview
- 4.8.3 Mylan Vitamin B12 (Cobalamin, Cyanocobalamin) Sales, Revenue and Gross Margin (2021-2026)
- 4.8.4 Mylan Vitamin B12 (Cobalamin, Cyanocobalamin) Product Portfolio
- 4.8.5 Mylan Recent Developments
- 4.9 Bayer HealthCare
- 4.9.1 Bayer HealthCare Company Information
- 4.9.2 Bayer HealthCare Business Overview
- 4.9.3 Bayer HealthCare Vitamin B12 (Cobalamin, Cyanocobalamin) Sales, Revenue and Gross Margin (2021-2026)
- 4.9.4 Bayer HealthCare Vitamin B12 (Cobalamin, Cyanocobalamin) Product Portfolio
- 4.9.5 Bayer HealthCare Recent Developments
- 4.10 Pfizer
- 4.10.1 Pfizer Company Information
- 4.10.2 Pfizer Business Overview
- 4.10.3 Pfizer Vitamin B12 (Cobalamin, Cyanocobalamin) Sales, Revenue and Gross Margin (2021-2026)
- 4.10.4 Pfizer Vitamin B12 (Cobalamin, Cyanocobalamin) Product Portfolio
- 4.10.5 Pfizer Recent Developments
- 4.11 ANGELINI
- 4.11.1 ANGELINI Company Information
- 4.11.2 ANGELINI Business Overview
- 4.11.3 ANGELINI Vitamin B12 (Cobalamin, Cyanocobalamin) Sales, Revenue and Gross Margin (2021-2026)
- 4.11.4 ANGELINI Vitamin B12 (Cobalamin, Cyanocobalamin) Product Portfolio
- 4.11.5 ANGELINI Recent Developments
- 4.12 Biological E
- 4.12.1 Biological E Company Information
- 4.12.2 Biological E Business Overview
- 4.12.3 Biological E Vitamin B12 (Cobalamin, Cyanocobalamin) Sales, Revenue and Gross Margin (2021-2026)
- 4.12.4 Biological E Vitamin B12 (Cobalamin, Cyanocobalamin) Product Portfolio
- 4.12.5 Biological E Recent Developments
- 4.13 CCEPCD
- 4.13.1 CCEPCD Company Information
- 4.13.2 CCEPCD Business Overview
- 4.13.3 CCEPCD Vitamin B12 (Cobalamin, Cyanocobalamin) Sales, Revenue and Gross Margin (2021-2026)
- 4.13.4 CCEPCD Vitamin B12 (Cobalamin, Cyanocobalamin) Product Portfolio
- 4.13.5 CCEPCD Recent Developments
- 4.14 Huaxin Pharmaceutical
- 4.14.1 Huaxin Pharmaceutical Company Information
- 4.14.2 Huaxin Pharmaceutical Business Overview
- 4.14.3 Huaxin Pharmaceutical Vitamin B12 (Cobalamin, Cyanocobalamin) Sales, Revenue and Gross Margin (2021-2026)
- 4.14.4 Huaxin Pharmaceutical Vitamin B12 (Cobalamin, Cyanocobalamin) Product Portfolio
- 4.14.5 Huaxin Pharmaceutical Recent Developments
- 4.15 RLG Group
- 4.15.1 RLG Group Company Information
- 4.15.2 RLG Group Business Overview
- 4.15.3 RLG Group Vitamin B12 (Cobalamin, Cyanocobalamin) Sales, Revenue and Gross Margin (2021-2026)
- 4.15.4 RLG Group Vitamin B12 (Cobalamin, Cyanocobalamin) Product Portfolio
- 4.15.5 RLG Group Recent Developments
5 Global Vitamin B12 (Cobalamin, Cyanocobalamin) Market Scenario by Region
- 5.1 Global Vitamin B12 (Cobalamin, Cyanocobalamin) Market Size by Region: 2021 VS 2025 VS 2032
- 5.2 Global Vitamin B12 (Cobalamin, Cyanocobalamin) Sales by Region: 2021-2032
- 5.2.1 Global Vitamin B12 (Cobalamin, Cyanocobalamin) Sales by Region: 2021-2026
- 5.2.2 Global Vitamin B12 (Cobalamin, Cyanocobalamin) Sales by Region: 2027-2032
- 5.3 Global Vitamin B12 (Cobalamin, Cyanocobalamin) Revenue by Region: 2021-2032
- 5.3.1 Global Vitamin B12 (Cobalamin, Cyanocobalamin) Revenue by Region: 2021-2026
- 5.3.2 Global Vitamin B12 (Cobalamin, Cyanocobalamin) Revenue by Region: 2027-2032
- 5.4 North America Vitamin B12 (Cobalamin, Cyanocobalamin) Market Facts & Figures by Country
- 5.4.1 North America Vitamin B12 (Cobalamin, Cyanocobalamin) Market Size by Country: 2021 VS 2025 VS 2032
- 5.4.2 North America Vitamin B12 (Cobalamin, Cyanocobalamin) Sales by Country (2021-2032)
- 5.4.3 North America Vitamin B12 (Cobalamin, Cyanocobalamin) Revenue by Country (2021-2032)
- 5.4.4 United States
- 5.4.5 Canada
- 5.4.6 Mexico
- 5.5 Europe Vitamin B12 (Cobalamin, Cyanocobalamin) Market Facts & Figures by Country
- 5.5.1 Europe Vitamin B12 (Cobalamin, Cyanocobalamin) Market Size by Country: 2021 VS 2025 VS 2032
- 5.5.2 Europe Vitamin B12 (Cobalamin, Cyanocobalamin) Sales by Country (2021-2032)
- 5.5.3 Europe Vitamin B12 (Cobalamin, Cyanocobalamin) Revenue by Country (2021-2032)
- 5.5.4 Germany
- 5.5.5 France
- 5.5.6 U.K.
- 5.5.7 Italy
- 5.5.8 Russia
- 5.5.9 Spain
- 5.5.10 Netherlands
- 5.5.11 Switzerland
- 5.5.12 Sweden
- 5.5.13 Poland
- 5.6 Asia Pacific Vitamin B12 (Cobalamin, Cyanocobalamin) Market Facts & Figures by Country
- 5.6.1 Asia Pacific Vitamin B12 (Cobalamin, Cyanocobalamin) Market Size by Country: 2021 VS 2025 VS 2032
- 5.6.2 Asia Pacific Vitamin B12 (Cobalamin, Cyanocobalamin) Sales by Country (2021-2032)
- 5.6.3 Asia Pacific Vitamin B12 (Cobalamin, Cyanocobalamin) Revenue by Country (2021-2032)
- 5.6.4 China
- 5.6.5 Japan
- 5.6.6 South Korea
- 5.6.7 India
- 5.6.8 Australia
- 5.6.9 Taiwan
- 5.6.10 Southeast Asia
- 5.7 South America Vitamin B12 (Cobalamin, Cyanocobalamin) Market Facts & Figures by Country
- 5.7.1 South America Vitamin B12 (Cobalamin, Cyanocobalamin) Market Size by Country: 2021 VS 2025 VS 2032
- 5.7.2 South America Vitamin B12 (Cobalamin, Cyanocobalamin) Sales by Country (2021-2032)
- 5.7.3 South America Vitamin B12 (Cobalamin, Cyanocobalamin) Revenue by Country (2021-2032)
- 5.7.4 Brazil
- 5.7.5 Argentina
- 5.7.6 Chile
- 5.8 Middle East and Africa Vitamin B12 (Cobalamin, Cyanocobalamin) Market Facts & Figures by Country
- 5.8.1 Middle East and Africa Vitamin B12 (Cobalamin, Cyanocobalamin) Market Size by Country: 2021 VS 2025 VS 2032
- 5.8.2 Middle East and Africa Vitamin B12 (Cobalamin, Cyanocobalamin) Sales by Country (2021-2032)
- 5.8.3 Middle East and Africa Vitamin B12 (Cobalamin, Cyanocobalamin) Revenue by Country (2021-2032)
- 5.8.4 Egypt
- 5.8.5 South Africa
- 5.8.6 Israel
- 5.8.7 Türkiye
- 5.8.8 GCC Countries
6 Segment by Type
- 6.1 Global Vitamin B12 (Cobalamin, Cyanocobalamin) Sales by Type (2021-2032)
- 6.1.1 Global Vitamin B12 (Cobalamin, Cyanocobalamin) Sales by Type (2021-2032) & (K Units)
- 6.1.2 Global Vitamin B12 (Cobalamin, Cyanocobalamin) Sales Market Share by Type (2021-2032)
- 6.2 Global Vitamin B12 (Cobalamin, Cyanocobalamin) Revenue by Type (2021-2032)
- 6.2.1 Global Vitamin B12 (Cobalamin, Cyanocobalamin) Sales by Type (2021-2032) & (US$ Million)
- 6.2.2 Global Vitamin B12 (Cobalamin, Cyanocobalamin) Revenue Market Share by Type (2021-2032)
- 6.3 Global Vitamin B12 (Cobalamin, Cyanocobalamin) Price by Type (2021-2032)
7 Segment by Application
- 7.1 Global Vitamin B12 (Cobalamin, Cyanocobalamin) Sales by Application (2021-2032)
- 7.1.1 Global Vitamin B12 (Cobalamin, Cyanocobalamin) Sales by Application (2021-2032) & (K Units)
- 7.1.2 Global Vitamin B12 (Cobalamin, Cyanocobalamin) Sales Market Share by Application (2021-2032)
- 7.2 Global Vitamin B12 (Cobalamin, Cyanocobalamin) Revenue by Application (2021-2032)
- 7.2.1 Global Vitamin B12 (Cobalamin, Cyanocobalamin) Sales by Application (2021-2032) & (US$ Million)
- 7.2.2 Global Vitamin B12 (Cobalamin, Cyanocobalamin) Revenue Market Share by Application (2021-2032)
- 7.3 Global Vitamin B12 (Cobalamin, Cyanocobalamin) Price by Application (2021-2032)
8 Value Chain and Sales Channels Analysis of the Market
- 8.1 Vitamin B12 (Cobalamin, Cyanocobalamin) Value Chain Analysis
- 8.1.1 Vitamin B12 (Cobalamin, Cyanocobalamin) Key Raw Materials
- 8.1.2 Raw Materials Key Suppliers
- 8.1.3 Vitamin B12 (Cobalamin, Cyanocobalamin) Production Mode & Process
- 8.2 Vitamin B12 (Cobalamin, Cyanocobalamin) Sales Channels Analysis
- 8.2.1 Direct Comparison with Distribution Share
- 8.2.2 Vitamin B12 (Cobalamin, Cyanocobalamin) Distributors
- 8.2.3 Vitamin B12 (Cobalamin, Cyanocobalamin) Customers
9 Global Vitamin B12 (Cobalamin, Cyanocobalamin) Analyzing Market Dynamics
- 9.1 Vitamin B12 (Cobalamin, Cyanocobalamin) Industry Trends
- 9.2 Vitamin B12 (Cobalamin, Cyanocobalamin) Industry Drivers
- 9.3 Vitamin B12 (Cobalamin, Cyanocobalamin) Industry Opportunities and Challenges
- 9.4 Vitamin B12 (Cobalamin, Cyanocobalamin) Industry Restraints
10 Report Conclusion
11 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst